최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기대한한방내과학회지 = The journal of internal Korean medicine, v.37 no.3, 2016년, pp.453 - 466
정현식 (단국대학교 대학원 생명융합학과) , 이상헌 (단국대학교 대학원 생명융합학과) , 유화승 (대전대학교 둔산한방병원 동서암센터) , 김경석 (단국대학교 대학원 생명융합학과)
Objective: The purpose of this study was to present the clinical practice guideline of Korean medicine for malignant lymphoma.Background: Malignant lymphoma is the tenth most common cancer in Korea. The two main types of lymphoma are Hodgkin’s disease and non-Hodgkin’s lymphoma. Non-Ho...
Minister of Health and Welfare. Korea Central Cancer Research. Annual report of cancer statistics in Korea in 2013. 2015.
Eom SK. Disease recognition of tumor, bump or mass until Han dynasty. J Oriental Medical Classics 2008;21(2):39-47.
Chen XY, Li DY. Combination therapy of malignant lymphoma. Beijing: Chemical Industry Press medical publishing branch; 2008.
Field MJ, Lohr KN. Clinical practice guidelines: directions for a new program. Washington, DC: National Academy Press; 1990.
Lin HS. Clinical practice guideline of Traditional Chinese Medicine for Cancer. Beijing: People's Health Publishing House; 2014, p. 540-66.
Korean Society of Hematology. Hematology. Seoul: Panmuneducation. 2011, p. 368-401.
Chen XY, Xu YM. Exploration to Traditional Chinese Medicine syndrome and common symptom of malignant lymphoma(stone gangrene). Beijing Traditional Chinese Medicine 2012;31(10):727-9.
Zhao ZZ, Lin HS. Exploration to relationship between syndrome and prognosis of malignant lymphoma. Beijing Traditional Chinese Medicine 2011;30(11):807-9.
Cha HJ, Huh JR. Pathologic Characteristics and Differential Diagnosis of Hodgkin Lymphoma. The Korean Journal of Medicine 2011;81(5) :543-53.
Elias C, Steven HS, Nancy LH, Stefano P, Harald S, et al. The WHO classification of lymphoid neoplasms and beyound: evolving concepts and practical applications. Blood 2011; 117(19):5019-31.
A predictive model for aggressive non-Hodgkin lymphoma. The international Non-Hodgkin lymphoma prognostic factor project. N Engl J Med 1993;329:987-94.
National Comprehensive Cancer Network, Hodgkin lymphoma 2015. Available from:URL:http://www.nccn.org/professionals/physician_gls/f_guidelines.asp
Kim JM, Ko YH, Lee SS, Huh JR, Kang CS, Kim CW, et al. WHO Classification of Malignant Lymphomas in Korea: Report of the Third Nationwide Study. The Korean Journal of Pathology 2011;45:254-60.
National Comprehensive Cancer Network, Non-Hodgkin lymphoma 2015. Available from:URL:http://www.nccn.org/professionals/physician_gls/f_guidelines.asp
Coiffier B, Thiebleomont C, Van D, Lepeu G, Plantier I, Castaigne S, et al. Long term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patient: a study by the Groupe d'Etudes des Lymphomes de L'Adult. Blood 2010;116:2040-45.
Kim YS, Yoon SW. Herb medications on angiocentric T-cell lymphoma with intra-abdominal metastasis: a case report. J of Kor Oriental Oncology 2005; 10(1):93-8.
Han SS, Cho CK, Lee YW, Yoo HS. A Case Report on Extra nodal Marginal Zone B Cell of Mucosa-associated Lymphoid Tissue (MALT) Type Lymphoma Treated with Hangam-dan. Korean J Orient Int Med 2008;29(3):810-9.
Kim IS, Cheong MS, Oh HS, Lee YS. Case of a Diffuse Large B-Cell Lymphoma Patient Treated with Traditional Korean Medicine Treatment. Korean J Oriental Physiology & Pathology 2014;28(2):233-7.
Choi SH, Song AN, An JH, Kim EH, Park SJ, Kim KS, et al. A Case Study of Soeumin with Peripheral T-cell Lymphoma who Showed Symptomatic Improvement including Fever, Myalgia, Performance Status, and Headache after Treated with Osuyubujaijung-tang and Geopoong-san. J Sasang Constitut Med 2012; 24(4):100-8.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.